REVLIMID (Lenalidomide) Maintenance Therapy Approved for Multiple Myeloma Patients

REVLIMID (Lenalidomide) Maintenance Therapy Approved for Multiple Myeloma Patients

User Photo
roswellpark

3 years
852 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Philip McCarthy, MD, Director of the Blood and Marrow Transplant Center at Roswell Park Cancer Institute in Buffalo, NY, shares benefits of lenalidomide maintenance therapy for multiple myeloma patients.
Up Next Autoplay